Preclinical data show that prenatal/early postnatal exposure to AhR ligands leads to a reprogramming of the CD4+ and CD8+ T cell responses to viral infection, via the long-term maintenance of alterations in DNA methylation [71,72]. This evidence concerns the gene CD8A and viral infectious disease.